Edge Therapeutics, Inc. (EDGE) News

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FO...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Edge Therapeutics, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed under Rule...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Edge Therapeutics, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed under Rule...

Securities Registration: Employee Benefit Plan (s-8)

As filed with the Securities and Exchange Commission on February 22, 2019. Registration No. 333 ‑ SECURI...

Annual Report (10-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Edge Therapeutics, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-6(b...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...

Edge Therapeutics Announces Full Year 2018 Financial Results

BERKELEY HEIGHTS, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today...

Confidential Treatment Order (ct Order)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration Statement No.: 333-228937  ...

Amended Statement of Ownership (sc 13g/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...